Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Most studies report successful nanoparticle formation within the 0.55 mM concentration range
Aardvark Therapeutics Sector: Oral gut-restricted bitter taste receptor agonists for hunger suppression HQ: San Diego, CA Year Founded: 2017 Origin Story: Aardvark Therapeutics was founded around a mechanistically distinct hypothesis: rather than suppressing appetite like GLP-1 drugs, the companys lead compound activates bitter taste receptors (TAS2Rs) confined to the gastrointestinal tract to trigger local release of satiety hormones, targeting hunger itself without systemic drug exposure
L-
The powder should dissolve completely within 30 to 60 seconds, leaving a clear liquid
The breakdown happens in tissues through normal metabolic pathways, not in a single organ, which is why clearance takes time
